Italian study illuminates positive outcomes and common complications of SING IMT implantation

News
Article

The implant was tested in eyes of patients with bilateral age-related macular degeneration who underwent cataract surgery

A map of Italy with a magnifying glass resting atop it. Image credit: ©sharafmaksumov – stock.adobe.com

This study evaluated the anatomic and functional outcomes of the SING IMT in patients with bilateral advanced age-related macular degeneration. Image credit: ©sharafmaksumov – stock.adobe.com

Investigators from the Department of Translational Medicine, University of Ferrara, and Sant’Anna University Hospital, both in Ferrara, Italy, conducted a study in which they evaluated the Smaller-Incision New Generation Implantable Miniature Telescope (SING IMT, Samsara Vision).

The authors reported that the device provided “promising objective results.” However, patients commonly reported unexplained blurred or hazy vision postoperatively that require further investigation,1 according to first author Ginevra Giovanna Adamo, MD.

This study evaluated the anatomic and functional outcomes of the SING IMT in patients with bilateral advanced age-related macular degeneration (AMD).

All patients in this non-comparative, retrospective, interventional case series included patients with bilateral late-stage AMD who underwent cataract surgery and implantation of the SING IMT at the Sant’Anna University Hospital. All procedures were performed by the same surgeon. The main outcomes were measurement of the corrected distance visual acuity (CDVA), near VA (CNVA) and the degree of endothelial cell loss (ECL). The investigators also recorded any complications that developed.

Results with the SING IMT

Dr Adamo and colleagues reported that 11 eyes of 11 study patients had a mean follow-up time of 6.5 ± 2.4 months.

The corrected distance and the corrected near VAs improved significantly. The CDVA improved from 17.00 ± 9.74 to 26.00 ± 8.53) letters (P = 0.008 and the CNVA improved from 12.27 ± 4.36 to 8 ± 2.61 Jaeger levels; P = 0.004). The mean ECL was 4.8% ± 5.5% at 3 months. No complications developed intraoperatively.

According to the investigators, postoperative complications developed that included iris incarceration (9.1%), pigment deposition on the device (9.1%) and transient corneal oedema (27.3%).

Ten of the eleven patients (90.9%) reported blurred or hazy vision within 3 months postoperatively, which resulted in explantation in three patients (27.3%).

Dr Adamo and colleagues concluded, “Although SING IMT implantation is associated with promising objective results, unexplained blurred or hazy vision represents common postoperative complaints, which may lead to patient dissatisfaction. Further studies including patient-reported outcomes are warranted to evaluate the effect of the intervention on patients’ visual function and quality of life.”

Reference

Adamo GG, Pellegrini M, Nasini F, et al. Anatomical and functional results of patients with late-stage age-related macular degeneration 6 months after smaller-incision new-generation implantable miniature telescope (SING IMT™) implantation. Eye. 2025;39:544-547; https://doi.org/10.1038/s41433-025-03598-4

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.